A New Noninvasive Option Arrives for Facet-Related Low Back Pain

Federal regulators recently cleared a focused ultrasound system that calms overactive nerves in the lower back's facet joints without a single incision, and the first patients started receiving it earlier this year.

A Fresh Entry in the Back Pain Toolbox

Most people who deal with a stubborn low back have already tried the usual lineup: rest, stretching, physical therapy, maybe an injection or two. Late last year, a device manufacturer called FUSMobile received a De Novo authorization from the FDA, a pathway reserved for genuinely new categories of medical technology, for a system built specifically around one common driver of chronic back pain: irritated facet joints.

The clearance is narrow and specific by design. It applies to patients whose back pain has lasted at least six months, is traced to the small facet joints that stack along the spine, and has already been confirmed through a diagnostic nerve block showing temporary relief. That kind of targeted criteria matters, because it means the treatment is aimed at people who already have a strong clinical reason to believe their pain is coming from that exact source, rather than being offered as a catch-all fix.

How the Technology Actually Works

The device, marketed as the Neurolyser XR, relies on high-intensity focused ultrasound guided by live x-ray imaging. In plain terms, sound waves are aimed and concentrated at a very precise point along the small medial branch nerves that run near the facet joints in the lumbar spine. Where those beams converge, the energy gently heats the nerve tissue enough to interrupt its ability to carry pain signals, a process sometimes called neurolysis.

Because the energy is delivered from outside the body and focused only at the target point, there is no incision, no implanted hardware, and no general anesthesia required for the procedure itself. That puts it in a different category from surgical fusion or implanted stimulators, and closer in spirit to existing nerve-based options like radiofrequency ablation, though the underlying energy source and delivery method are different.

From Pivotal Trial to Real Clinics

Before reaching this point, the device went through a pivotal United States trial conducted across ten separate clinical sites, part of a development effort the company has described as spanning more than a decade. The system had already picked up regulatory approval in Canada, a CE Mark covering the European Union, and registration in the United Kingdom before the FDA's clearance arrived.

With the US clearance in place, 2026 has brought the first commercial procedures performed stateside, with early adopters among interventional pain practices choosing to add the option alongside their existing injection and ablation menus. It is still a young rollout, so widespread availability and real-world outcomes data will take time to build out.

Why the Timing Matters for So Many Patients

Back pain remains one of the most common reasons Americans see a doctor at all. National health survey data from the CDC found that close to four in ten adults reported back pain within just a three-month window, and separate estimates suggest the large majority of those cases stem from mechanical causes rather than anything structurally alarming, like muscle strain, disc wear, or joint irritation rather than fracture or nerve damage.

Facet joints are a well-recognized piece of that mechanical picture, especially as people get older and those small joints develop arthritis-like changes. Having another noninvasive tool aimed specifically at that source gives patients and their doctors one more option to weigh alongside physical therapy, injections, and ablation, rather than jumping straight to more invasive procedures when conservative care has not been enough.

What This Means If You're Weighing Your Options

It is worth being realistic about where this technology stands today. It is brand new to the US market, availability is limited to select clinics for now, and like any facet-focused treatment it is not a fit for every type of back pain, only pain that has been traced specifically to those joints. Nobody should assume a device is right for their situation based on a headline alone.

If persistent back pain has been part of your routine, the most useful next step is usually a conversation with a qualified provider who can look at your specific history and imaging before recommending anything. That is exactly the kind of conversation our team at Las Vegas Spine & Disc is glad to have; booking a consult costs nothing but a little time, and it is the surest way to find out what actually fits your situation.

Where Facet Ultrasound Fits Among Current Back Pain Options

Focused ultrasound facet ablation joins an already crowded field of conservative and minimally invasive choices. Here is roughly how it stacks up against familiar approaches.

1. Physical therapy and exercise: Usually the first line of care, focused on strengthening and mobility rather than targeting a single nerve or joint.
2. Oral medications: Anti-inflammatories or muscle relaxants that manage symptoms but do not address a specific structural cause.
3. Facet joint steroid injections: A common diagnostic and short-term relief step, often the same test used to confirm a patient is a candidate for nerve-based treatments.
4. Radiofrequency ablation: An established, needle-based technique that uses heat from radio waves to interrupt the same medial branch nerves.
5. Focused ultrasound neurolysis: The newly cleared, noninvasive alternative that uses sound energy delivered from outside the body instead of a needle.
6. Neurostimulation devices: Implanted systems aimed at chronic pain signaling for patients who have not responded to more conservative measures.
7. Surgical options: Reserved for cases with clear structural problems that have not improved with the less invasive approaches above.

← More from the Las Vegas Spine & Disc blog